SEC-MALS Determination of Absolute Molar Mass and Oligomeric State for a Purified Protein in Solution

The protein is run at three loading amounts (25, 50, 100 µg in 100 µL) to test concentration-dependent oligomerization and mass accuracy, each in triplicate injections (9 runs), preceded by a BSA standard run for detector normalization/calibration and band-broadening correction. A buffer-blank injection brackets the series. A single analytical SEC column appropriate to the expected mass range is used at a constant flow rate. Inter-detector delay volumes and the dn/dc value (0.185 mL/g for typical proteins, or measured) are fixed for the analysis.

BSL-1 for non-pathogenic recombinant proteins. Hazards are minimal and chemical: TCEP and HEPES buffers are mild irritants; some running buffers contain sodium azide as a preservative (toxic, collect as hazardous waste, never mix with acids or down copper/lead plumbing). Wear nitrile gloves, safety glasses, and a lab coat. The HPLC/FPLC operates under pressure; follow column pressure limits to avoid bursts, and relieve pressure before disconnecting fittings. Dispose of azide-containing buffer as hazardous chemical waste.

Positive/calibration control: BSA standard run that must report monomer at ~66.4 kDa (and a partially resolved dimer at ~133 kDa), validating detector normalization, delay volumes, and band-broadening parameters. Negative control: buffer-only blank injection to confirm no scattering artifacts, bubbles, or column bleed. dn/dc control: confirm the assumed 0.185 mL/g is appropriate (or measure it for glycosylated/conjugated proteins). Concentration series controls for mass-loading-dependent oligomerization and detector saturation.

A monodisperse protein gives a single symmetric peak with a flat molar-mass plateau whose value equals the monomer mass x integer (e.g., a 50 kDa monomer reporting ~100 kDa indicates a dimer), typically within +/-2-5% of sequence-predicted, and polydispersity Mw/Mn ~1.00-1.02 across the peak. Aggregates appear as an early-eluting peak/shoulder with rising mass; concentration-dependent mass increase indicates reversible self-association. BSA control should report ~66.4 kDa monomer within ~5% and Mw/Mn near 1.0.

• Purified protein in a filtered, degassed running buffer (e.g., 20 mM HEPES pH 7.5, 150 mM NaCl, 1 mM TCEP), 0.22 µm-filtered
• Analytical SEC column matched to mass range (e.g., a silica or agarose-based 24 mL column with appropriate fractionation range)
• BSA standard (monomer ~66.4 kDa) for detector normalization and band-broadening calibration, 2 mg/mL
• Running buffer, 0.1-0.22 µm-filtered and degassed, identical to sample buffer
• 0.22 µm centrifugal filters and 0.1 µm in-line filters
• HPLC/FPLC system with isocratic pump and degasser
• MALS detector, in-line UV (A280) detector, and differential refractive index (dRI) detector in series

To determine the absolute molar mass, mass distribution, and oligomeric state of a purified protein (and to detect aggregation or non-ideal behavior) using SEC coupled in-line to multi-angle light scattering (MALS), UV (A280), and differential refractive index (dRI) detectors, independent of column calibration standards.

1. Filter (0.1-0.22 µm) and degas the running buffer; equilibrate the entire flow path (pump, column, MALS, UV, dRI) until the MALS and dRI baselines are flat and stable (typically 1-2 column volumes).
2. Centrifuge each sample at 16,000 x g, 10 min, 4 C to remove aggregates and air; keep samples cold.
3. Inject 100 µL of BSA standard (200 µg) at the operating flow rate; use the monomer peak to normalize MALS detector angles, determine inter-detector delays, and calibrate band broadening.
4. Run a buffer-blank injection to confirm baseline cleanliness.
5. Inject the protein at 25, 50, and 100 µg, triplicate each, at constant flow (e.g., 0.5 mL/min), collecting MALS, UV, and dRI continuously.
6. For each peak, set integration limits and compute molar mass across the peak using the light-scattering data with concentration from dRI (dn/dc = 0.185 mL/g) or UV (extinction coefficient).
7. Inspect the molar-mass-vs-elution trace for a flat plateau across the main peak (monodispersity) and quantify any aggregate or higher-order species.
8. Wash/store the column per manufacturer instructions after the series.

Independent: protein loading amount (25/50/100 µg). Dependent: weight-average molar mass (Mw), number-average mass (Mn), polydispersity (Mw/Mn), oligomeric state, aggregate percentage. Controlled: running buffer composition, flow rate, column, temperature, injection volume, dn/dc, extinction coefficient, detector normalization (from BSA), inter-detector delay and band-broadening parameters, sample prep (centrifugation).

A correctly folded, monodisperse protein injected onto a calibrated SEC-MALS system will elute as a single symmetric peak whose MALS/dRI-derived weight-average molar mass equals an integer multiple of the sequence-predicted monomer mass (within ~5%), confirming a defined and homogeneous oligomeric state; aggregated or polydisperse samples will show mass that varies across the peak.

Process chromatograms in the instrument software (e.g., ASTRA or equivalent): normalize MALS angles using BSA, set band-broadening and delay corrections, define peak limits, and compute Mw, Mn, Mw/Mn, and mass distribution using Zimm or Debye fits with concentration from dRI (dn/dc) and/or UV. Report mass-vs-volume overlay, percent monomer vs aggregate by mass, and the radius (Rg) only if above the MALS detection limit (>~10 nm). Normalize across runs to the BSA calibration; average triplicate masses.

1. Noisy/drifting MALS or dRI baseline: degas and 0.1 µm-filter buffer, purge bubbles, allow longer equilibration, check for column bleed. 2. Mass higher than expected/rising across peak: aggregation or column overload; centrifuge sample, reduce load, or improve buffer (salt, reducing agent). 3. BSA monomer mass off by >5%: re-normalize detectors, verify inter-detector delay and band-broadening, check dn/dc. 4. Peak tailing/poor resolution: column fouled or flow too fast; clean/replace column, lower flow rate, filter samples. 5. Concentration mismatch between UV and dRI: confirm extinction coefficient and dn/dc, check for non-protein UV absorbers (nucleotides, detergents).

Report the mean +/- SD of Mw across triplicate injections at each loading; the analytical precision target is CV < 5%. Compare Mw across the three loading amounts by one-way ANOVA with Tukey HSD (alpha = 0.05) to test for concentration-dependent oligomerization (a non-significant difference supports a fixed oligomeric state). Compare measured Mw to the predicted monomer/oligomer mass by a one-sample t-test against the theoretical value. n = 3 injections per condition gives a stable mean; reproducibility confirmed on an independent protein prep.